Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling, joint tenderness, and destruction of synovial joints, leading to severe disability and premature mortality1. RA is considered an autoimmune disease. Autoimmunity and the overall systemic and articular inflammatory load drive the destructive progression of the disease. However, although structural changes, which can be visualized by conventional radiography or other imaging techniques, best distinguish RA from other arthritic disorders joint damage is rarely apparent in the very early stages of disease, but rather accumulates consistently over time.

It has been recognized that early therapeutic intervention improves clinical outcomes and reduces the accrual of joint damage and disability1.

The cause of RA is not yet fully understood, although doctors do know that an abnormal response of the immune system plays a leading role in the inflammation and joint damage that occurs2.

If you are effected by rheumatoid arthritis, you may qualify for a research study currently assessing the safety and efficacy of a new medication designed to treat this condition.

Qualified participants will be compensated for time and travel. Study medications and study related care are provided at no cost, without the need for health insurance.

Help us discover new treatments and ease the discomfort experienced by so many. Take a moment to volunteer by completing the form below.

A Study Volunteer Specialist will contact you when a study fitting your interest is available.

 

Reference 1. Aletaha, D., & Neogi, T. et al. 2010 Rheumatoid Arthritis Classification Criteria. ARTHRITIS & RHEUMATISM Vol. 62, No. 9, September 2010, pp 2569–2581, American College of Rheumatology.

2. Rheumatoid Arthritis Causes .From http://www.arthritis.org/about-arthritis/types/rheumatoid-arthritis/causes.php 

Clinical Trials

Other paid studies